Statements (16)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:monoclonal_antibody
|
gptkbp:administeredBy |
intravenous infusion
|
gptkbp:approvalYear |
2016
|
gptkbp:approvedBy |
gptkb:U.S._Food_and_Drug_Administration
|
gptkbp:ATCCode |
J06BC04
|
gptkbp:developedBy |
gptkb:Human_Genome_Sciences
|
gptkbp:genericName |
gptkb:obiltoxaximab
|
https://www.w3.org/2000/01/rdf-schema#label |
ABthrax
|
gptkbp:legalStatus |
prescription only
|
gptkbp:marketedAs |
GlaxoSmithKline
|
gptkbp:routeOfAdministration |
intravenous
|
gptkbp:target |
gptkb:Bacillus_anthracis_protective_antigen
|
gptkbp:usedFor |
treatment of inhalational anthrax
prevention of inhalational anthrax |
gptkbp:bfsParent |
gptkb:Raxibacumab
|
gptkbp:bfsLayer |
6
|